CompletedNot Applicable

PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare

United States1,377 participantsStarted 2023-09-22

Plain-language summary

The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient of UAB GYN clinic Exclusion Criteria: * Not a patient of UAB GYN clinic

What they're measuring

PrEP Prescriptions

Timeframe: 8 months

Trial details

NCT IDNCT07209722

SponsorUniversity of Alabama at Birmingham

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-16

Results submitted2025-12-03

View on ClinicalTrials.gov More PrEP Precriptions for Reproductive Aged Women trials